MARKET

AXGT

AXGT

Axovant Gene Therapies
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.50
-0.19
-2.47%
Closed 16:00 09/16 EDT
OPEN
7.75
PREV CLOSE
7.69
HIGH
8.05
LOW
7.45
VOLUME
186.50K
TURNOVER
--
52 WEEK HIGH
20.80
52 WEEK LOW
3.810
MARKET CAP
170.86M
P/E (TTM)
-1.2375
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AXGT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AXGT News

  • Axovant (AXGT) Gains As Market Dips: What You Should Know
  • Zacks.com.3d ago
  • Axovant Gene Therapies Ltd. (NASDAQ:AXGT): What Does Its Beta Value Mean For Your Portfolio?
  • Simply Wall St..4d ago
  • Voyager Therapeutics: An Alternative Read On Parkinson's Asset Phase 1b Data
  • Seeking Alpha - Article.09/09 16:34
  • Mitsubishi Tanabe launches late-stage study in U.S. for continuous Parkinson's therapy
  • Seeking Alpha - Article.08/28 14:26

More

Industry

Biotechnology & Medical Research
+0.97%
Pharmaceuticals & Medical Research
-0.15%

Hot Stocks

Name
Price
%Change

About AXGT

Axovant Gene Therapies Ltd., formerly Axovant Sciences Ltd., is a clinical-stage biopharmaceutical company. The Company is focused on acquiring, developing and commercializing therapeutics for the treatment of dementia, including Alzheimer's disease and Lewy body dementia. The Company intends to develop a pipeline of product candidates to address the cognitive, functional and behavioral aspects of dementia and related neurological disorders. The Company also focuses on developing nelotanserin, a selective 5-hydroxytryptamine 2A receptor inverse agonist, for the treatment of rapid eye movement (REM) behavior disorder (RBD) in DLB patients, and visual hallucinations in patients with Lewy body dementia. Its AXO-Lenti-PD is an in vivo lentiviral gene therapy investigational product candidate and being developed for the one-time treatment of Parkinson’s disease.
More

Webull offers Axovant Gene Therapies Ltd (AXGT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.